This study is comparing two types of surgery for early-stage cervical cancer: robotic-assisted hysterectomy (using the da Vinci device) versus traditional open surgery. Researchers want to see if robotic surgery is just as effective as open surgery in helping patients live longer. You might be able to join if you are a woman, 18 or older, and have been diagnosed with certain types of early cervical cancer (FIGO Stage IA2, IBI, IB2) without signs of the cancer spreading. The main goal is to measure survival after 36 months. The current status of this study is unclear, and it plans to enroll about 840 participants.

Study design

This is a randomized controlled trial, meaning participants are randomly assigned to one of the two surgery types. It is an open-label study, so both you and your doctors will know which surgery you receive. The study aims to enroll 840 participants.

What's involved

Not specified in the trial record.

Compensation

Not stated in the trial record.

Follow-up

Your survival will be measured for 36 months after surgery.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.